Anzeige
Mehr »
Donnerstag, 02.10.2025 - Börsentäglich über 12.000 News
Starkes Upside-Potenzial: Wachstumsstory mit starken Gehalten und großem Explorationspotenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40MD0 | ISIN: US17322U3068 | Ticker-Symbol: 47N0
NASDAQ
01.10.25 | 21:58
1,355 US-Dollar
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
CITIUS PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
CITIUS PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur CITIUS PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CITIUS PHARMACEUTICALS Aktie jetzt für 0€ handeln
12.08.Citius Pharmaceuticals, Inc. - 8-K, Current Report1
12.08.Citius Pharmaceuticals GAAP EPS of -$0.081
12.08.Citius Pharmaceuticals, Inc. - 10-Q, Quarterly Report4
12.08.Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update180$12.5 million in gross financings raised during the quarter, with an additional $9 million raised by Citius Oncology in July 2025, to facilitate LYMPHIR pre-launch...
► Artikel lesen
08.07.Citius Pharmaceuticals, Inc. - 8-K, Current Report3
08.07.Citius Pharmaceuticals regains Nasdaq compliance3
08.07.Citius Pharmaceuticals, Inc.: Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement202CRANFORD, N.J., July 8, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) today announced that it has received...
► Artikel lesen
10.06.Citius Pharma Announces Direct Offering4
10.06.Citius Pharmaceuticals announces registered direct offering of $15.8 million2
10.06.Citius Pharma sichert sich 6 Millionen US-Dollar durch Aktienangebot4
09.06.Citius Pharmaceuticals, Inc. - 8-K, Current Report1
30.05.Citius Pharmaceuticals, Inc. - 8-K, Current Report3
14.05.Citius Pharmaceuticals GAAP EPS of -$0.11 beats by $0.276
14.05.Citius Pharmaceuticals, Inc. - 8-K, Current Report4
14.05.Citius Pharmaceuticals, Inc. - 10-Q, Quarterly Report4
14.05.Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update206 CRANFORD, N.J., May 14, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated...
► Artikel lesen
18.04.Citius Pharmaceuticals, Inc. - 8-K, Current Report4
14.04.Citius Pharmaceuticals stock price target cut to $4 from $100 at H.C. Wainwright3
14.02.Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update414CRANFORD, N.J., Feb. 14, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated...
► Artikel lesen
27.12.24Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update454Clinical and regulatory success in 2024 expected to drive value in 2025 CRANFORD, N.J., Dec. 27, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius...
► Artikel lesen
Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1